NAD+ IV

NAD+ stands for nicotinamide adenine dinucleotide - a coenzyme present in every single cell of your body. It is not an exotic molecule but one of the most central tools of metabolism, period. NAD+ cycles constantly between its oxidized (NAD+) and reduced form (NADH), shuttling electrons through the major energy pathways: glycolysis, the citric acid cycle and the respiratory chain.

The IV variant here is high-dose - 1000 mg of freeze-dried powder per vial, meant to be dissolved and given as a slow intravenous infusion in the research context. The idea behind it: orally taken NAD+ is largely broken down in the digestive tract before it arrives. An infusion bypasses that path and brings the substance directly into the bloodstream.

NAD+ IV has become popular in the wellness and longevity space. Important and honest: the controlled clinical evidence for the IV form is thin. The molecule itself is exceptionally well researched, the intravenous application by contrast has barely been tested in randomized studies. If you want to read deeper into the fundamentals, see the separate NAD+ lexicon entry. This information is for research and educational purposes only. No medical recommendations.

NAD+ has two fundamentally different jobs, and that is exactly what makes it so interesting.

First, as a redox coenzyme. In glycolysis, the citric acid cycle and at the mitochondrial respiratory chain, NAD+ picks up electrons and releases them again. Without enough NAD+, ATP production stalls - the cell cannot supply its energy efficiently. That is textbook biochemistry, not a speculative mechanism.

Second, as a substrate for NAD+-consuming enzymes. This is where the longevity angle sits. Sirtuins (especially SIRT1) are NAD+-dependent enzymes involved in gene regulation, DNA repair, mitochondrial function and the cellular stress response. PARPs (DNA repair) and CD38 also consume NAD+. Reviews describe that tissue NAD+ levels decline with age and that this drop is preclinically linked to numerous aging processes.

The logic of supplementation: raise NAD+ again so that sirtuins and repair enzymes have more substrate. In animal models this could be shown convincingly. In humans - and especially via the IV route - the evidence is considerably thinner.

NAD+ IV is different from a subcutaneous peptide. It is not injected with an insulin syringe but diluted and slowly infused intravenously. That belongs in skilled hands - an IV infusion is not a home DIY setup.

• The NAD+ vial with the freeze-dried powder (1000 mg)
• Sterile solution to dissolve and dilute (e.g. sterile or bacteriostatic water, then further into a larger infusion carrier solution)
• A sterile infusion set with the ability to set the flow rate slowly
• Alcohol swabs for the vial cap and the puncture site
• A sealable container for used needles

If you are not familiar with IV access: this is the kind of application where experience and sterile technique are decisive.

Two things need to be kept cleanly apart here: the basic research on NAD+ as a molecule (strong) and the clinical evidence for the IV application (thin).

On the biology: reviews paint a consistent picture. Covarrubias et al. (2020) describe how NAD+ influences energy metabolism, DNA repair, chromatin and senescence, and how tissue levels fall with age. Imai & Guarente (2014) laid out the NAD+-sirtuin axis early as an aging-relevant mechanism. Rajman et al. (2018) summarize the in vivo evidence for NAD+-boosting molecules - much of it convincing in animal models, more open in humans.

On the IV route specifically: the most important human work is the pilot study by Grant et al. (2019). They infused NAD+ into healthy individuals over 6 hours and tracked plasma and urine metabolites. Surprisingly: in the first 2 hours there was hardly any change in plasma NAD+ - the infused NAD+ was apparently removed from the plasma very quickly and completely and metabolized. Only later did metabolites and excretion products appear. That is a pure pharmacokinetic description, not a proof of efficacy.

Controlled studies demonstrating a clinical benefit of NAD+ IV for anti-aging or wellness endpoints are largely missing. That is the honest state: strong mechanistic foundation, popular practice, but thin outcome evidence specifically for the infusion.

By far the most common observation is pace-dependent: if the infusion runs too fast, flush (heat, redness), pressure in the chest or head, tightness, nausea, abdominal cramps or a general feeling of being unwell appear. These reactions typically ease once you slow the pace down - the reason the infusion should run slowly.

As with any intravenous application, the generic IV risks come on top: pain or irritation at the puncture site, and with poor technique an infection risk. Sterile technique is not optional here.

Honest on the data: because controlled long-term studies on the IV form are missing, the full side-effect profile under repeated use is not well characterized. What is known is mainly the acute, pace-dependent effects.

The undissolved powder is robust, normal room temperature (around 20 to 25 degrees) is fine, ideally kept in the dark. Keep dissolved solution in the fridge (2 to 8 degrees). NAD+ is sensitive in solution, so a freshly prepared solution is preferable to long storage - use it promptly rather than keeping it for weeks.